|
"jen chung ko"的相關文件
顯示項目 1-50 / 61 (共2頁)
1 2 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2022-06-10T06:24:21Z |
Downregulation of p38 MAPK Activation and Radiation-Sensitive 52 Expression Enhances 5-Fluorouracil and Erlotinib-Induced Cytotoxicity in Human Lung Squamous Cells
|
JEN-CHUNG KO |
| 臺大學術典藏 |
2022-06-10T06:24:20Z |
Nitroglycerin-induced downregulation of AKT- and ERK1/2-mediated radiation-sensitive 52 expression to enhance pemetrexed-induced cytotoxicity in human lung cancer cells
|
JEN-CHUNG KO |
| 臺大學術典藏 |
2021-07-14T07:15:22Z |
Functional Status After Pulmonary Rehabilitation as a Predictor of Weaning Success and Survival in Patients Requiring Prolonged Mechanical Ventilation
|
JEN-CHUNG KO; LI-TA KENG; SHENG-KAI LIANG; PING-HSIEN TSOU; CHIA-HAO CHANG; LIH-YU CHANG; KAI-LUN YU; MENG-RUI LEE; Tseng, Chi-Ping ; Wen, Yueh-Feng |
| 臺大學術典藏 |
2021-07-14T07:15:21Z |
Efficacy and safety of cone-beam computed tomography-derived augmented fluoroscopy combined with endobronchial ultrasound in peripheral pulmonary lesions
|
JEN-CHUNG KO; KAI-LUN YU; SHUN-MAO YANG; Ko H.-J. ; Tsai H.-Y. ; Lin C.-K. ; Ho C.-C. ; Shih J.-Y. |
| 臺大學術典藏 |
2021-07-14T07:15:21Z |
Exploring volatile organic compounds in breath for high-accuracy prediction of lung cancer
|
JEN-CHUNG KO; PING-HSIEN TSOU; CHIEN-JEN CHANG; SHENG-KAI LIANG; CHIA-HAO CHANG; LIH-YU CHANG; KAI-LUN YU; LI-TA KENG; MENG-RUI LEE; Zong-Lin Lin ; Yu-Chiang Pan ; Hui-Chen Yang ; Yueh-Feng Wen ; Chia-Jung Liu ; Guan-Hua Huang and Yaw-Kuen Li |
| 臺大學術典藏 |
2021-03-03T06:40:41Z |
Cross-talk between SOX2 and TGFb signaling regulates EGFR-TKI tolerance and lung cancer dissemination
|
Kuo, Ming Han; Lee, An Chun; Hsiao, Shih Hsin; Lin, Sey En; Chiu, Yu Fan; Yang, Li Hao; Yu, Chia Cherng; Chiou, Shih Hwa; Hsien-Neng Huang; JEN-CHUNG KO; Chou, Yu Ting |
| 臺大學術典藏 |
2021-02-08T08:05:10Z |
Effect of beta-Blocker in Treatment-Naive Patients With Advanced Lung Adenocarcinoma Receiving First-Generation EGFR-TKIs
|
JEN-CHUNG KO; CHIA-HAO CHANG; LIH-YU CHANG; Lee, Chih-Hsin ; Lee, Ming-Chia ; Zhang, Jun-Fu ; Wang, Jann-Yuan ; Shih, Jin-Yuan ; Yu, Chong-Jen |
| 臺大學術典藏 |
2021-02-08T08:05:09Z |
Downregulation of xeroderma pigmentosum complementation group c expression by 17-allylamino-17-demethoxygeldanamycin enhances bevacizumab-induced cytotoxicity in human lung cancer cells
|
JEN-CHUNG KO; Chen, Jyh-Cheng ; Taso, Yong-Cing ; Cheng, Hsiang-Hung ; Chen, Tzu-Ying ; Yen, Ting-Chuan ; Lin, Yun-Wei |
| 臺大學術典藏 |
2021-02-08T08:05:08Z |
Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort
|
Jen-Chung Ko;Sheng-Kai Liang;Li-Ta Keng;Chia-Hao Chang;Yueh-Feng Wen ; Meng-Rui Lee ; Ching-Yao Yang ; Jann-Yuan Wang ; Jin-Yuan Shih ; Chong-Jen Yu; JEN-CHUNG KO; SHENG-KAI LIANG; LI-TA KENG; CHIA-HAO CHANG; Yueh-Feng Wen ; Meng-Rui Lee ; Ching-Yao Yang ; Jann-Yuan Wang ; Jin-Yuan Shih ; Chong-Jen Yu |
| 臺大學術典藏 |
2021-02-02T09:21:39Z |
Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort
|
SHENG-KAI LIANG; LI-TA KENG; CHIA-HAO CHANG; Wen, Yueh Feng; MENG-RUI LEE; Yang, Ching Yao; JANN-YUAN WANG; JEN-CHUNG KO; JIN-YUAN SHIH; CHONG-JEN YU |
| 臺大學術典藏 |
2020-07-17T09:53:20Z |
Seroprevalence of Aspergillus IgG and disease prevalence of chronic pulmonary aspergillosis in a country with intermediate burden of tuberculosis: a prospective observational study
|
JEN-CHUNG KO; Meng Rui Lee; Huang, H.-L. ; Chen, L.-C. ; Yang, H.-C. ; Cheng, M.-H. ; Chong, I.-W. ; Lee, L.-N. ; Wang, J.-Y. ; Dimopoulos, G. |
| 臺大學術典藏 |
2020 |
Nontuberculous mycobacterial lung disease epidemiology in Taiwan: A systematic review
|
JEN-CHUNG KO; Meng Rui Lee; Lih Yu Chang; Wang, Hao-Chien ; Huang, Yi-Wen |
| 臺大學術典藏 |
2019-12-18T06:15:23Z |
Tuberculosis contact investigation in an intermediate burden setting: implications from a large tuberculosis contact cohort in Taiwan
|
Ho, Cheng-Maw Lee, Chih-Hsin; Lee, Ming-Chia; Wang, Jann-Yuan; Wang, Jann-Tay; Lee, Li-Na;LIH YU CHANG;KAI LUN YU;MENG RUI LEE;JEN-CHUNG KO; JEN-CHUNG KO; MENG RUI LEE; KAI LUN YU; LIH YU CHANG; Ho, Cheng-Maw Lee, Chih-Hsin; Lee, Ming-Chia; Wang, Jann-Yuan; Wang, Jann-Tay; Lee, Li-Na |
| 臺大學術典藏 |
2019-12-18T06:15:23Z |
Tuberculosis contact investigation in an intermediate burden setting: implications from a large tuberculosis contact cohort in Taiwan
|
Ho, Cheng-Maw Lee, Chih-Hsin; Lee, Ming-Chia; Wang, Jann-Yuan; Wang, Jann-Tay; Lee, Li-Na;LIH YU CHANG;KAI LUN YU;MENG RUI LEE;JEN-CHUNG KO; JEN-CHUNG KO; MENG RUI LEE; KAI LUN YU; LIH YU CHANG; Ho, Cheng-Maw Lee, Chih-Hsin; Lee, Ming-Chia; Wang, Jann-Yuan; Wang, Jann-Tay; Lee, Li-Na |
| 臺大學術典藏 |
2019-12-18T06:15:22Z |
Afatinib is effective in the treatment of lung adenocarcinoma with uncommon EGFR p.L747P and p.L747S mutations
|
Yang, James Chih-Hsin; Shih, Jin-Yuan;SHENG KAI LIANG;JEN-CHUNG KO; JEN-CHUNG KO; SHENG KAI LIANG; Yang, James Chih-Hsin; Shih, Jin-Yuan |
| 臺大學術典藏 |
2019-12-18T06:15:22Z |
Afatinib is effective in the treatment of lung adenocarcinoma with uncommon EGFR p.L747P and p.L747S mutations
|
Yang, James Chih-Hsin; Shih, Jin-Yuan;SHENG KAI LIANG;JEN-CHUNG KO; JEN-CHUNG KO; SHENG KAI LIANG; Yang, James Chih-Hsin; Shih, Jin-Yuan |
| 臺大學術典藏 |
2019-12-18T06:15:22Z |
Clinical impact of using fluoroquinolone with low antimycobacterial activity on treatment delay in tuberculosis: Hospital-based and population-based cohort study
|
MENG RUI LEE;Chih-Hsin Lee; Jann-Yuan Wang; Shih-Wei Lee; Li-Na Lee;JEN-CHUNG KO; JEN-CHUNG KO; Chih-Hsin Lee; Jann-Yuan Wang; Shih-Wei Lee; Li-Na Lee; MENG RUI LEE |
| 臺大學術典藏 |
2019-12-18T06:15:22Z |
Clinical impact of using fluoroquinolone with low antimycobacterial activity on treatment delay in tuberculosis: Hospital-based and population-based cohort study
|
MENG RUI LEE;Chih-Hsin Lee; Jann-Yuan Wang; Shih-Wei Lee; Li-Na Lee;JEN-CHUNG KO; JEN-CHUNG KO; Chih-Hsin Lee; Jann-Yuan Wang; Shih-Wei Lee; Li-Na Lee; MENG RUI LEE |
| 臺大學術典藏 |
2019-12-18T06:15:22Z |
Capsaicin enhances erlotinib-induced cytotoxicity: Via AKT inactivation and excision repair cross-complementary 1 (ERCC1) down-regulation in human lung cancer cells
|
JEN-CHUNG KO; Chen, Jyh-Cheng; Yen, Ting-Chuan; Chen, Tzu-Ying; Lin, Yuan-Cheng; Ma, Peng-Fang; Lin, Yun-Wei |
| 臺大學術典藏 |
2019-12-18T06:15:22Z |
Nitroglycerin Enhances Cisplatin-Induced Cytotoxicity via AKT Inactivation and Thymidylate Synthase Downregulation in Human Lung Cancer Cells
|
Chen, J.-C.; Yen, T.-C.; Chen, T.-Y.; Ma, P.-F.; Lin, Y.-C.; Cheng, H.-H.; Taso, Y.-C.; Lin, Y.-W.; JEN-CHUNG KO; Chen, J.-C.; Yen, T.-C.; Chen, T.-Y.; Ma, P.-F.; Lin, Y.-C.; Cheng, H.-H.; Taso, Y.-C.; Lin, Y.-W.;JEN-CHUNG KO |
| 臺大學術典藏 |
2019-12-18T06:15:22Z |
Nitroglycerin Enhances Cisplatin-Induced Cytotoxicity via AKT Inactivation and Thymidylate Synthase Downregulation in Human Lung Cancer Cells
|
Chen, J.-C.; Yen, T.-C.; Chen, T.-Y.; Ma, P.-F.; Lin, Y.-C.; Cheng, H.-H.; Taso, Y.-C.; Lin, Y.-W.; JEN-CHUNG KO; Chen, J.-C.; Yen, T.-C.; Chen, T.-Y.; Ma, P.-F.; Lin, Y.-C.; Cheng, H.-H.; Taso, Y.-C.; Lin, Y.-W.;JEN-CHUNG KO |
| 臺大學術典藏 |
2019-12-18T06:15:22Z |
Factors associated with improvement in symptoms and quality of life for first-line EGFR-tyrosine kinase inhibitor treatment in patients with EGFR-mutated non-small-cell lung cancer - A multicenter prospective SMILE study
|
JEN-CHUNG KO; Wei, Yu-Feng; Huang, Wen-Tsung; Liu, Tu-Chen; Shieh, Jiunn-Min; Chian, Chih-Feng; Wu, Ming-Fang; Chang, Chih-Cheng; Lin, Ching-Hsiung; Lin, Chia-Mo; Hsia, Te-Chun |
| 臺大學術典藏 |
2019-12-18T06:15:21Z |
Outcome of stage IV cancer patients receiving in-hospital cardiopulmonary resuscitation: a population-based cohort study
|
MENG RUI LEE;Liu, Tsung-Hao; Tsai, Jaw-Shiun; Wang, Jann-Yuan;HUNG YANG KUO;KAI LUN YU;JEN-CHUNG KO; JEN-CHUNG KO; KAI LUN YU; HUNG YANG KUO; Liu, Tsung-Hao; Tsai, Jaw-Shiun; Wang, Jann-Yuan; MENG RUI LEE |
| 臺大學術典藏 |
2019-12-18T06:15:21Z |
Outcome of stage IV cancer patients receiving in-hospital cardiopulmonary resuscitation: a population-based cohort study
|
MENG RUI LEE;Liu, Tsung-Hao; Tsai, Jaw-Shiun; Wang, Jann-Yuan;HUNG YANG KUO;KAI LUN YU;JEN-CHUNG KO; JEN-CHUNG KO; KAI LUN YU; HUNG YANG KUO; Liu, Tsung-Hao; Tsai, Jaw-Shiun; Wang, Jann-Yuan; MENG RUI LEE |
| 臺大學術典藏 |
2019-09-16T09:25:32Z |
Factors associated with improvement in symptoms and quality of life for first-line EGFR-tyrosine kinase inhibitor treatment in patients with EGFR-mutated non-small-cell lung cancer - A multicenter prospective SMILE study
|
JEN-CHUNG KO;Liu, Tu Chen;Hsia, Te Chun;Lin, Ching Hsiung;Chang, Chih Cheng;Wei, Yu Feng;Wu, Ming Fang;Chian, Chih Feng;Lin, Chia Mo;Shieh, Jiunn Min;Huang, Wen Tsung; Huang, Wen Tsung; Shieh, Jiunn Min; Lin, Chia Mo; Chian, Chih Feng; Wu, Ming Fang; Wei, Yu Feng; Chang, Chih Cheng; Lin, Ching Hsiung; Hsia, Te Chun; Liu, Tu Chen; JEN-CHUNG KO |
| 臺大學術典藏 |
2019-09-16T09:25:32Z |
Factors associated with improvement in symptoms and quality of life for first-line EGFR-tyrosine kinase inhibitor treatment in patients with EGFR-mutated non-small-cell lung cancer - A multicenter prospective SMILE study
|
JEN-CHUNG KO;Liu, Tu Chen;Hsia, Te Chun;Lin, Ching Hsiung;Chang, Chih Cheng;Wei, Yu Feng;Wu, Ming Fang;Chian, Chih Feng;Lin, Chia Mo;Shieh, Jiunn Min;Huang, Wen Tsung; Huang, Wen Tsung; Shieh, Jiunn Min; Lin, Chia Mo; Chian, Chih Feng; Wu, Ming Fang; Wei, Yu Feng; Chang, Chih Cheng; Lin, Ching Hsiung; Hsia, Te Chun; Liu, Tu Chen; JEN-CHUNG KO |
| 臺大學術典藏 |
2019-03-04T08:06:47Z |
Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: a real-world, large cohort study
|
Sheng-Kai Liang;Meng-Rui Lee;Wei-Yu Liao;Chao-Chi Ho;Jen-Chung Ko;Jin-Yuan Shih; SHENG-KAI LIANG; MENG-RUI LEE; WEI-YU LIAO; CHAO-CHI HO; JEN-CHUNG KO; JIN-YUAN SHIH |
| 臺大學術典藏 |
2019-03-04T08:06:47Z |
Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: a real-world, large cohort study
|
Sheng-Kai Liang;Meng-Rui Lee;Wei-Yu Liao;Chao-Chi Ho;Jen-Chung Ko;Jin-Yuan Shih; SHENG-KAI LIANG; MENG-RUI LEE; WEI-YU LIAO; CHAO-CHI HO; JEN-CHUNG KO; JIN-YUAN SHIH |
| 臺大學術典藏 |
2018-09-10T18:07:07Z |
Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study
|
Liang, S.-K. and Lee, M.-R. and Liao, W.-Y. and Ho, C.-C. and Ko, J.-C. and Shih, J.-Y.; MENG RUI LEE; Wei-Yu Liao; Chao-Chi Ho; Jin-Yuan Shih; JEN-CHUNG KO; SHENG-KAI LIANG |
| 臺大學術典藏 |
2018-09-10T18:06:04Z |
Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma
|
Liang, S.-K. and Hsieh, M.-S. and Lee, M.-R. and Keng, L.-T. and Ko, J.-C. and Shih, J.-Y.; MENG-RUI LEE; KENG LI-TA; JEN-CHUNG KO; SHENG-KAI LIANG; JIN-YUAN SHIH |
| 臺大學術典藏 |
2018-09-10T18:04:18Z |
Diabetes Mellitus and Latent Tuberculosis Infection: A Systemic Review and Metaanalysis
|
Lee, M.-R. and Huang, Y.-P. and Kuo, Y.-T. and Luo, C.-H. and Shih, Y.-J. and Shu, C.-C. and Wang, J.-Y. and Ko, J.-C. and Yu, C.-J. and Lin, H.-H.; CHIN-CHUNG SHU; Chong-Jen Yu; MENG-RUI LEE; JANN-YUAN WANG; HSIEN-HO LIN; JEN-CHUNG KO |
| 臺大學術典藏 |
2018-09-10T18:03:16Z |
Psychological distress and coping strategies among women with incurable lung cancer: a qualitative study
|
Liao, Y.-C. and Liao, W.-Y. and Sun, J.-L. and Ko, J.-C. and Yu, C.-J.; CHONG-JEN YU; WEI-YU LIAO; JEN-CHUNG KO |
| 臺大學術典藏 |
2018-09-10T18:01:48Z |
Gefitinib or erlotinib in previously treated non-small-cell lung cancer patients: A cohort study in Taiwan
|
Chang, C.-H. and Lee, C.-H. and Ko, J.-C. and Chang, L.-Y. and Lee, M.-C. and Wang, J.-Y. and Yu, C.-J.; Chong-Jen Yu; JANN-YUAN WANG; CHIA-HAO CHANG; JEN-CHUNG KO; LIH-YU CHANG |
| 臺大學術典藏 |
2018-09-10T15:34:32Z |
Acquisition of Mycobacterium abscessus among ventilator-dependent patients in Taiwan chronic respiratory care facilities
|
Lee, M.-R. and Tsai, C.-J. and Hu, J.-Y. and Lee, S.-W. and Ko, J.-C. and Wang, H.-C. and Yu, C.-J. and Lee, L.-N. and Hsueh, P.-R.; PO-REN HSUEH; LI-NA LEE; Chong-Jen Yu; MENG-RUI LEE; HAO-CHIEN WANG; JEN-CHUNG KO |
| 臺大學術典藏 |
2018-09-10T15:34:32Z |
Cementing an unwanted relationship
|
KENG LI-TA; JEN-CHUNG KO; CHIA-HAO CHANG; Chang, C.-H. and Keng, L.-T. and Ko, J.-C. |
| 臺大學術典藏 |
2018-09-10T15:34:32Z |
Salinomycin enhances cisplatin-induced cytotoxicity in human lung cancer cells via down-regulation of AKT-dependent thymidylate synthase expression
|
Ko, J.-C. and Zheng, H.-Y. and Chen, W.-C. and Peng, Y.-S. and Wu, C.-H. and Wei, C.-L. and Chen, J.-C. and Lin, Y.-W.; JEN-CHUNG KO; Zheng, Hao-Yu; Chen, Wen-Ching; Peng, Yi-Shuan; Wu, Chia-Hung; Wei, Chia-Li; Chen, Jyh-Cheng; Lin, Yun-Wei |
| 臺大學術典藏 |
2018-09-10T15:34:30Z |
Vorinostat enhances the cisplatin-mediated anticancer effects in small cell lung cancer cells
|
Pan, C.-H. and Chang, Y.-F. and Lee, M.-S. and Wen, B.-C. and Ko, J.-C. and Liang, S.-K. and Liang, M.-C.; Pan, Chun-Hao; Chang, Ying-Fang; Lee, Ming-Shuo; Wen, B-Chen; Liang, Mei-Chih; JEN-CHUNG KO; SHENG-KAI LIANG |
| 臺大學術典藏 |
2018-09-10T15:32:36Z |
Astaxanthin down-regulates Rad51 expression via inactivation of AKT kinase to enhance mitomycin C-induced cytotoxicity in human non-small cell lung cancer cells
|
Jen-Chung Ko and Jyh-Cheng Chen and Tai-Jing Wang and Hao-Yu Zheng and Wen-Ching Chen and Po-Yuan Chang and Yun-Wei Lin; JEN-CHUNG KO; Chen, Jyh-Cheng; Wang, Tai-Jing; Zheng, Hao-Yu; Chen, Wen-Ching; Chang, Po-Yuan; Lin, Yun-Wei |
| 臺大學術典藏 |
2018-09-10T15:19:23Z |
Resveratrol Enhances Etoposide-Induced Cytotoxicity through Down-Regulating ERK1/2 and AKT-Mediated X-ray Repair Cross-Complement Group 1 (XRCC1) Protein Expression in Human Non-Small-Cell Lung Cancer Cells
|
Ko, J.-C. and Syu, J.-J. and Chen, J.-C. and Wang, T.-J. and Chang, P.-Y. and Chen, C.-Y. and Jian, Y.-T. and Jian, Y.-J. and Lin, Y.-W.; JEN-CHUNG KO; Syu, Jhan-Jhang; Chen, Jyh-Cheng; Wang, Tai-Jing; Chang, Po-Yuan; Chen, Chien-Yu; Jian, Yun-Ting; Jian, Yi-Jun; Lin, Yun-Wei |
| 臺大學術典藏 |
2018-09-10T15:19:23Z |
Down-regulation of MSH2 expression by Hsp90 inhibition enhances cytotoxicity affected by tamoxifen in human lung cancer cells
|
Ko, J.-C. and Chiu, H.-C. and Syu, J.-J. and Chen, C.-Y. and Jian, Y.-T. and Huang, Y.-J. and Wo, T.-Y. and Jian, Y.-J. and Chang, P.-Y. and Wang, T.-J. and Lin, Y.-W.; JEN-CHUNG KO; hiu, Hsien-Chun; Syu, Jhan-Jhang; Chen, Chien-Yu; Jian, Yun-Ting; Huang, Yi-Jhen; Wo, Ting-Yu; Jian, Yi-Jun; Chang, Po-Yuan; Wang, Tai-Jing; Lin, Yun-Wei |
| 臺大學術典藏 |
2018-09-10T15:18:48Z |
Factors associated with subsequent nontuberculous mycobacterial lung disease in patients with a single sputum isolate on initial examination
|
Lee, M.-R. and Yang, C.-Y. and Shu, C.-C. and Lin, C.-K. and Wen, Y.-F. and Lee, S.-W. and Ko, J.-C. and Wang, J.-Y. and Lee, L.-N. and Yu, C.-J.; CHIN-CHUNG SHU; LI-NA LEE; MENG-RUI LEE; Chong-Jen Yu; JANN-YUAN WANG; JEN-CHUNG KO |
| 臺大學術典藏 |
2018-09-10T15:01:34Z |
Clinical characteristics and outcomes of patients with pleural infections due to Stenotrophomonas maltophilia at a medical center in Taiwan, 2004-2012
|
Lee, M.-R. and Wang, H.-C. and Yang, C.-Y. and Lin, C.-K. and Kuo, H.-Y. and Ko, J.-C. and Sheng, W.-H. and Lee, L.-N. and Yu, C.-J. and Hsueh, P.-R.; CHING-YAO YANG; PO-REN HSUEH; HAN-YUEH KUO; LI-NA LEE; Chong-Jen Yu; MENG-RUI LEE; HAO-CHIEN WANG; JEN-CHUNG KO; WANG-HUEI SHENG |
| 臺大學術典藏 |
2018-09-10T14:53:50Z |
Tamoxifen enhances erlotinib-induced cytotoxicity through down-regulating AKT-mediated thymidine phosphorylase expression in human non-small-cell lung cancer cells
|
Ko, J.-C. and Chiu, H.-C. and Syu, J.-J. and Jian, Y.-J. and Chen, C.-Y. and Jian, Y.-T. and Huang, Y.-J. and Wo, T.-Y. and Lin, Y.-W.; JEN-CHUNG KO; Chiu, Hsien-Chun; Syu, Jhan-Jhang; Jian, Yi-Jun; Chen, Chien-Yu; Jian, Yun-Ting; Huang, Yi-Jhen; Wo, Ting-Yu; Lin, Yun-Wei |
| 臺大學術典藏 |
2018-09-10T14:51:28Z |
Bacteraemia caused by Mycobacterium abscessus subsp. abscessus and M. abscessus subsp. bolletii: Clinical features and susceptibilities of the isolates
|
MENG-RUI LEE; JEN-CHUNG KO; SHENG-KAI LIANG; Lee, M.-R. and Ko, J.-C. and Liang, S.-K. and Lee, S.-W. and Yen, D.H.-T. and Hsueh, P.-R.; PO-REN HSUEH |
| 臺大學術典藏 |
2018-09-10T09:17:44Z |
HSP90 inhibition induces cytotoxicity via down-regulation of Rad51 expression and DNA repair capacity in non-small cell lung cancer cells
|
Ko, J.-C. and Chen, H.-J. and Huang, Y.-C. and Tseng, S.-C. and Weng, S.-H. and Wo, T.-Y. and Huang, Y.-J. and Chiu, H.-C. and Tsai, M.-S. and Chiou, R.Y.Y. and Lin, Y.-W.; JEN-CHUNG KO; Chen, Huang-Jen; Huang, Yu-Ching; Tseng, Sheng-Chieh; Weng, Shao-Hsing; Wo, Ting-Yu; Huang, Yi-Jhen; Chiu, Hsien-Chun; Tsai, Min-Shao; Chiou, Robin Y. Y.; Lin, Yun-Wei |
| 臺大學術典藏 |
2018-09-10T08:35:38Z |
Up-regulation of extracellular signal-regulated kinase 1/2-dependent thymidylate synthase and thymidine phosphorylase contributes to cisplatin resistance in human non-small-cell lung cancer cells
|
Ko, J.-C. and Tsai, M.-S. and Chiu, Y.-F. and Weng, S.-H. and Kuo, Y.-H. and Lin, Y.-W.; JEN-CHUNG KO; Tsai, Min-Shao; Chiu, Yu-Fan; Weng, Shao-Hsing; Kuo, Ya-Hsun; Lin, Yun-Wei |
| 臺大學術典藏 |
2018-09-10T08:35:38Z |
Modulation of Rad51, ERCC1, and thymidine phosphorylase by emodin result in synergistic cytotoxic effect in combination with capecitabine
|
Ko, J.-C. and Tsai, M.-S. and Kuo, Y.-H. and Chiu, Y.-F. and Weng, S.-H. and Su, Y.-C. and Lin, Y.-W.; JEN-CHUNG KO; Tsai, Min-Shao; Kuo, Ya-Hsun; Chiu, Yu-Fan; Weng, Shao-Hsing; Su, Ying-Chen; Lin, Yun-Wei |
| 臺大學術典藏 |
2018-09-10T08:35:38Z |
Curcumin enhances the mitomycin C-induced cytotoxicity via downregulation of MKK1/2-ERK1/2-mediated Rad51 expression in non-small cell lung cancer cells
|
Ko, J.-C. and Tsai, M.-S. and Weng, S.-H. and Kuo, Y.-H. and Chiu, Y.-F. and Lin, Y.-W.; JEN-CHUNG KO; Tsai, Min-Shao; Weng, Shao-Hsing; Kuo, Ya-Hsun; Chiu, Yu-Fan; Lin, Yun-Wei |
| 臺大學術典藏 |
2018-09-10T08:09:11Z |
Suppression of ERCC1 and Rad51 expression through ERK1/2 inactivation is essential in emodin-mediated cytotoxicity in human non-small cell lung cancer cells
|
Ko, J.-C. and Su, Y.-J. and Lin, S.-T. and Jhan, J.-Y. and Ciou, S.-C. and Cheng, C.-M. and Lin, Y.-W.; JEN-CHUNG KO; Su, Ying-Jhen; Lin, Szu-Ting; Jhan, Jhih-Yuan; Ciou, Shih-Ci; Cheng, Chao-Min; Lin, Yun-Wei |
| 臺大學術典藏 |
2018-09-10T08:09:11Z |
Emodin enhances cisplatin-induced cytotoxicity via down-regulation of ERCC1 and inactivation of ERK1/2
|
Ko, J.-C. and Su, Y.-J. and Lin, S.-T. and Jhan, J.-Y. and Ciou, S.-C. and Cheng, C.-M. and Chiu, Y.-F. and Kuo, Y.-H. and Tsai, M.-S. and Lin, Y.-W.; JEN-CHUNG KO; Su, Ying-Jhen; Lin, Szu-Ting; Jhan, Jhih-Yuan; Ciou, Shih-Ci; Cheng, Chao-Min; Chiu, Yu-Fan; Kuo, Ya-Hsun; Tsai, Min-Shao; Lin, Yun-Wei |
顯示項目 1-50 / 61 (共2頁)
1 2 > >>
每頁顯示[10|25|50]項目
|
